Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism.
Burke
G W
GW
University of Miami School of Medicine, Department of Surgery, FL 33136, USA.
Alejandro
R
R
Roth
D
D
Colona
J
J
Contreras
N
N
Ciancio
G
G
Skyler
J S
JS
Ricordi
C
C
Nery
J
J
Tzakis
A
A
D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D005947:Glucose / Q000378:metabolism*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006084:Graft Rejection / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000502:physiology; D050356:Lipid Metabolism; D016035:Pancreas Transplantation / Q000009:adverse effects* / Q000502:physiology; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D002096:C-Peptide; D002784:Cholesterol; D003404:Creatinine; D005947:Glucose; D006442:Glycated Hemoglobin; D007166:Immunosuppressive Agents; D016559:Tacrolimus; D014280:Triglycerides